Lantheus Announces Presentation at the 2021 American Urological Association (AUA) Annual Meeting
Lantheus Holdings, Inc. (LNTH)
Last lantheus holdings, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.lantheus.com/investor-relations
Company Research
Source: GlobeNewswire
Highlights Piflufolastat F 18’s Potential to Change Initial Risk Assessment and Intended Patient Management in High-Risk Prostate Cancer Identified Regional Lymph Node and/or Distant Metastases in 26.9% of Patients Prior to Definitive Therapy NORTH BILLERICA, Mass., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, announced that data from the OSPREY pivotal trial on the utility of piflufolastat F 18 (previously referred to as 18F-DCFPyL or PyL) during initial assessment on men with high risk prostate cancer were presented at the 2021 American Urological Association (AUA) Virtual Annual Meeting. Piflufolastat F 18 is Lantheus’ prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agent. The OS
Show less
Read more
Impact Snapshot
Event Time:
LNTH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNTH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNTH alerts
High impacting Lantheus Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
LNTH
News
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Lantheus Holdings (LNTH) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
- Is Most-Watched Stock Lantheus Holdings, Inc. (LNTH) Worth Betting on Now? [Yahoo! Finance]Yahoo! Finance
- Investing in Lantheus Holdings (NASDAQ:LNTH) three years ago would have delivered you a 198% gain [Yahoo! Finance]Yahoo! Finance
- Lantheus (LNTH) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance]Yahoo! Finance
LNTH
Earnings
- 2/22/24 - Beat
LNTH
Sec Filings
- 3/19/24 - Form 4
- 3/15/24 - Form 4
- 3/15/24 - Form 144
- LNTH's page on the SEC website